Mylan

News

FDA rejects Sunovion's nebulised COPD drug

The US regulator has rejected Sunovion’s nebulised therapy for chronic obstructive pulmonary disease (COPD), leaving the company struggling to stay ahead of rivals.

News

GSK gets short term boost as second US Advair generic reject...

FDA rejects Hikma drug, regulator has "major" issue with Mylan's rival.

News

US court orders GSK to pay $3m after generic Paxil suicide l...

Order comes after man commits suicide taking generic version of GSK's Paxil.

News

Mylan recalls pricey US EpiPens, but cheaper version unaffec...

More trouble for embattled Mylan.

News

Breathing space for GSK as Mylan's Advair copy rejected

Stay of execution for ageing blockbuster

News

Mylan recalls 81,000 EpiPens after reports of failures

Recall follows two reports that allergy injection device failed.

FDA rejects Sunovion's nebulised COPD drug

GSK gets short term boost as second US Advair generic reject...

US court orders GSK to pay $3m after generic Paxil suicide l...

Mylan recalls pricey US EpiPens, but cheaper version unaffec...

Breathing space for GSK as Mylan's Advair copy rejected

Mylan recalls 81,000 EpiPens after reports of failures

FDA points to liver injury with Amgen's Tavneos

Using AI-driven synthetic personas to take your insights fur...

Mylan

Editor's Picks